Determination of in Vitro Susceptibilities of Candida Strains Isolated From Clinical Specimens as Pathogen to Systemic Antifungal Agents: [Klinik Örneklerden Patojen Etken Olarak İzole Edilen Candida Suşlarının Sistemik Etkili Antifungal Ajanlara Duyarlılıkları]

Hüseyin Gün; Mustafa Özyurt; Tuncer Haznedaroğlu; Mehmet Baysallar

doi:10.58600/eurjther-199342-1095-x

Authors

Hüseyin Gün GATA Mikrobiyoloji ve Klinik Mikrobiyoloji ABD Bşk. Doç.Dr.
Mustafa Özyurt GATA Mikrobiyoloji ve Klinik Mikrobiyoloji ABD. Dr.
Tuncer Haznedaroğlu GATA Mikrobiyoloji ve Klinik Mikrobiyoloji ABD. Yrd.Doç.Dr.
Mehmet Baysallar GATA Mikrobiyoloji ve Klinik Mikrobiyoloji ABD. Yrd.Doç.Dr.

DOI:

https://doi.org/10.58600/eurjther-199342-1095-x

Keywords:

Candida, antifungal agents, susceptibility

Abstract

In this study, susceptibilities of 50 Candida strain isolated and identified from clinical specimens as pathogen to systemic antifungal agents including amphotericin-B, flucanozole, ketocanozole and miconazole nitrate using Macro Dilution method and results were discussed in a view of literature data.

Metrics

Metrics Loading ...

References

Freeman BA.:Medical Mycology the Pathogenic Fungi and the Pathogenic Actinomychetes. Burrows Textbook of Microbiology 22 th ed. W.B. Saunders Company, 1985. 874-937.

Kasımoğlu Ö., Aktan G.:1990-91 Döneminde Çeşitli Muayene Maddelerinden İnfeksiyon Etkeni Olarak İzole Edilen Mayalar. Ankem Dergisi, 6:(No.2), 1992 (80)(7. Türk Ankem Kongre Bildirisi).

Pfizer International Inc.:Candida, The Growing Problem. New York, 1987, 1-34.

Bodey GP.:Candidiasis in Cancer Patients.Am.J.Med.77:(Suppl.4D), 13-19, 1984.

Bodey GP. ,Anaissie EJ:Opportunistic Fungal Infections;A ma jor Problem in Immunocompromised Patients. The Am.Journal of Medicine, 1984, 1-16.

Gold JWM.:Opportunistic Fungal lnfections in Patients with Neoplastic Disease. Thc Am.Journal of Medicine, 76:458-463, March 1984.

Tümbay E., İnci R.:Antifungal Kemoterapi Türk Mikrobiyoloji Cemiyeti Yayınlan, No:17, 16-35, 1992.

Warren NG., Shadomy HJ,;Yeasts of Medical lmportance. Manual of Clinical Microbiology 5 th, Edition, (Ed.s.) Balows, A., Hausler, W.J., Hermann, K.L., Isenberg, H,D., Shadomy, H.J., Am,Soc, for Miy, Washington D.C., 1991, 617-629.

Tiimbay ll,:Sistemik Etkili Yeni Bir Antifungal Kemoterapötik Flukonazol, infeksiyon Dergisi (Turkish Journal of lnfection), 3:(l), (1989 Ek baskı Seri no:1), 1989.

Dreizen S,:Oral Candidiasis. The Am, Journal of Medicine, 30:28-33, Oct.l984.

Nicholas RO., Kerridge D, :Drug Resistance in the Opportunistic; Pathogens C.albicans and C.glabrata, Journal of Antimicrobial Chemotherapy, 18:Suppl. ll,39-49, 1986.

Saag MS,, Dismukes WE.: Minireview, Azole Antifungal Agents, Emphasis on New Triatzoles, Antimicrobial Agent and Chemotherapy, 32:(1), 1·8, Jan., 1988.

Shadomy S., Ingroff EA: In Vitro and In Vivo Evaluation of Antifungal Agents, Evr. J. Clin. Microbial.Infect.Dis., 8:(4), 352-361, April, 1989.

Yüce K: Antibiyotikler ve İnfeksiyon Hastalıklarında Tedavi Prensipleri, Ege Üniversitesi Tıp Fakültesi Yayınları, İzmir, Bornova, 1988. S. 87-90.

Pfaller MA, Burmeister L., Bartlett MS, Rinaldi MG.:Multicenter Evaluation of Four Methods of Yeast lnokulum Preparation. Joumal of Clinical Microbiology, 26:143-1441, Aug., 1988.

Shadomy S., Pfaller MA,:Laboratory Studies with Antifungal Agents Susceptibility Tests and Quantitation in Body Fluids, Manual of Clinicııl Microbiology 5 th. Edition, (Eds.) Balows, A,, Hausler, W.J., Hermann K.L., Isenberg, H,D., Shadomy, H,J,, Am,Soc,for Microbiology, Washington D.C. 1991, 1173-1181.

Galgiani JN., Reiser J., Brass C., Espinel IA., Gordon MA, and Kerkering TM,:Comparison of Relative Susceptibilities of Candida Species to Three Antifungal Agents as Detemined by Unstandardized Methods. Antimicrobial Agentsand Chemotherapy, 31:(9), 1343-1347, Sept. 1987,

Merz WG,:Susceptibility Testing of Medically Important Fungi. Adv,Exp. Med,Biol., 202:127-134, 1986.

Galgiani JN.:Mini Review Antifungal Agents and Chemotherapy, 31:(12), 1867-1870, Des., 1987.

Galgiııni JN., Mcintyre KA.:ln Vitro Susceptibilities of Yeasts to A New Antifungal Triazole SCH 39304, Effeçts of Test Conditions and Relııtion to in Vivo Efficacy. Antimicrobial Agents and Chemotherapy, 33:(7), 1095-1100, July 1989.

Kobayashl GS., Odds FC.:Current Perspectives on Antifungal Susceptibility Testing. Focus on Fluconazole First Printing, Scientific Therapeutics İnforrnation, ine., 1989, 1-26.

Ingroff AE., Kerkering TM., Goldsan PR., Shadomy S.:Comparison Study of Broth Macrodilution and Microdilution Antifungal Susceptibility Tests. Journal of Clinlcal Microbiology, 29:1089-1094, June, 1991.

Anaissie E., Paetanick V. and Dodey GP.:Fluconazole Susceptibility Testing of C.albicans: Microtiter Method that is lndependent of lnoculum Size, Temperature and Time of Ceading. Antimicrobial Agents and Chemotherapy, 35:1641-1646, Aug. 1991.

PfalJer MA., Rinaldi MG., Galgiani JN., Bartlett MS., Body BA., lnroff EA., Fromtling RA, HalJ GS., Huaghes CE., Odds FC. and Sugar AM.:Collaborative Investigation of Variables in Susceptibility, Testing of Yeasts. Antimicrobial Agents and Chemotherapy, 34:1648-1654, Sept., 1990.

Galgiani JN.,Calhoun DL.:Analysis of pH and Buffer Effects on Flucytosine Activity in Broth Dilution Susceptibility Testing of Candida albicans in Two Synthetic Media. Antimicrobial Agents and Chemotherapy, 26:(3), 364-367, Sept. 1984.

Gordon MA., Lapa EW. and Passero PG.:Improved Method for Azole Antifungal Susceptibility Testing. Joumal of Oinical Microbiology, 26:1874-1884, Sept., 1988.

Radetsky M., Wheeler RC., Roe MH. and Todd JK.:Microtiter Broth Dilution Method far Yeast Susceptibility Testing with Validation by Clinical Outcome. Journal of Clinical Microbiology, 24:600-606, Oct., 1986.

Rogers TE. and Galgiani JN.:Activity of Fluconazole (UK 49, B 58) and Ketoconazole, Against C.albicans in Vitro and in Vivo. Antimicrobial Agents and Chemotherapy, 30:(3), 418-422, Sept., 1986.

Ghannoum MA., Sharif HF ., Charreer H.:Sensitivity of Clinical Yeast lsolates in Kuwait Against a Number of Antifungal Agents. Mykosen, 27:(8), 402-410, 1984.

Ahearn DG., Ghohn Mc.Ms.:ln Vitro Susceptibilities of Sucrose-Negative C.tropicalis, C.lusitaniac and C.norvegensis to Amphotericin-B, 5-Fluorocytosine, Miconazole and Ketoconazole. Joumal of Oinical Microbiology, 19:412-416, March 1984.P.

Surarit R., Maxwell GS.:The Effects of Azole and Polyene Antifungals on the Plazma Membrane Enzymes of C.albicans. Joumal of Medical and Veterinary Mycology, 25:403-413, 1987.